Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Insurance coverage sits at the center of this dementia and brain health question.
Insurance coverage gaps are forcing families to delay critical neurological care, with claim denials hitting 11.8% in 2024 and advanced imaging requests—essential for diagnosing dementia and other brain disorders—being rejected at rates as high as 24%. A 75-year-old woman experienced firsthand what this means: her neurologist recommended an MRI to evaluate early cognitive decline, but her insurance denied the request without explanation. By the time the family successfully appealed three weeks later, her symptoms had progressed further, and the window for early intervention had narrowed.
This article explores how insurance barriers are delaying necessary neurological care, the systems that perpetuate these delays, and what families can do to navigate them. The gap between what neurologists recommend and what insurance companies approve has widened significantly in recent years. Prior authorization requirements—the process by which insurers must pre-approve treatments—are stalling care for patients with dementia, stroke, Parkinson’s disease, and other serious neurological conditions. The consequences aren’t just inconvenient; nearly one in four physicians report that prior authorization delays have caused serious adverse patient outcomes, and some families are forced to choose between financial ruin and postponing care altogether.
Table of Contents
- Why Insurance Denials Hit Neurological Care Harder
- Prior Authorization: The Hidden Cost of Delays
- 2026 Coverage Gaps: A Perfect Storm for Neurological Patients
- The Financial Burden on Families Navigating Insurance Barriers
- Serious Adverse Events: When Delays Cause Harm
- Appealing Denials and Fighting Back
- The Systemic Problem and Future Outlook
- Conclusion
Why Insurance Denials Hit Neurological Care Harder
Claim denials have increased across healthcare, but neurological care faces unique challenges. Advanced imaging like MRI and PET scans—the gold standard for diagnosing dementia and detecting stroke risk—are being denied at twice the rate of routine diagnostics. Some national insurers reject over 30% of advanced imaging requests, forcing families and physicians into lengthy appeals that can take weeks or months to resolve. A family seeking an MRI for a 68-year-old member showing early signs of Alzheimer’s might receive a denial letter claiming the test is “not medically necessary,” even though the referring neurologist has documented cognitive decline and the imaging is standard protocol for diagnosis. The problem is compounded by inconsistency.
Two patients at the same neurological practice with identical symptoms might receive different coverage decisions from the same insurer, depending on factors like their specific plan, deductible status, or the administrator handling the case. insurance companies employ medical reviewers—who may not be neurologists—to make determinations about complex neurological treatments, and their decisions are often based on cost-containment rather than clinical evidence. A 2024 report found initial claim denials at 11.8%, up from 10.2% in prior years, with nearly three-quarters of surveyed patients reporting that denials have increased in frequency. The financial burden of fighting denials falls on patients and doctors. While the official timeline for insurance response is 3-5 days minimum, patients sometimes wait weeks or months for approval letters. During this wait, neurological conditions don’t stand still: a transient ischemic attack (TIA) can progress to full stroke, early cognitive decline can advance to moderate dementia, and medication adjustments recommended by a neurologist remain unimplemented.
Prior Authorization: The Hidden Cost of Delays
Prior authorization is the single biggest bottleneck in neurological care today. Neurologists report completing an average of 29.1 prior authorization requests per week, consuming 14.6 hours per physician just to handle paperwork. This administrative burden exists on top of patient care, and it’s a burden that has increased significantly: 88% of physicians say the prior authorization burden has grown substantially in recent years. The delay in approval directly impacts patient outcomes. According to American Medical Association data, 94% of physicians report that prior authorization delays patient care, and the consequences are serious. Nearly 1 in 4 physicians (23%) have observed serious adverse patient events—including disease progression, emergency department visits, and hospitalizations—that directly resulted from prior authorization delays. For neurological conditions like dementia, where early intervention can slow cognitive decline, a three-week delay in obtaining an MRI can mean the difference between treatable and advanced disease.
Consider a scenario where a primary care doctor suspects mild cognitive impairment and refers a patient to a neurologist for further evaluation. The neurologist recommends an MRI to rule out vascular dementia and other reversible causes. The insurance company requires prior authorization and requests additional documentation. The back-and-forth takes 2-3 weeks. By the time the MRI is approved and scheduled, the patient’s family has noticed more pronounced memory loss, and the opportunity for early intervention has narrowed. However, if the patient or their family proactively requests expedited review and documents urgent neurological symptoms—such as acute stroke signs, rapidly progressing weakness, or suspected normal-pressure hydrocephalus—insurers sometimes accelerate approval. The key is understanding that routine timelines are not guaranteed and that families have the right to request expedited processing when immediate neurological evaluation could prevent serious harm.
2026 Coverage Gaps: A Perfect Storm for Neurological Patients
The insurance landscape is deteriorating in 2026. Five million adults age 50 and older are at risk as ACA premium tax credits expire at the end of 2025, with some families facing monthly premium increases of hundreds of dollars—money that might have gone toward neurological care is now going to insurance premiums. Simultaneously, millions of Americans are losing Medicaid coverage as eligibility reviews resume in 2026 after a four-year pause during the pandemic. For a family supporting an aging parent with early-stage dementia, this means potential loss of coverage right when cognitive decline is accelerating. Higher out-of-pocket costs are driving patients to delay routine neurological visits, skip recommended lab work, and reduce medication use. An 80-year-old on a dementia medication prescribed by a neurologist might skip doses to stretch a month’s supply across six weeks if cost-sharing increases.
A 72-year-old with a family history of Alzheimer’s might forego recommended cognitive testing if it requires an out-of-pocket payment. This pattern of delaying care due to cost isn’t unusual—it’s becoming the norm. Rising deductibles, narrowing provider networks, and increasing copayments are all widening the gap between recommended neurological care and care that families can actually afford. A limitation of this coverage crisis is that it affects different populations unequally. Wealthy families with supplemental insurance or the ability to pay out-of-pocket can sometimes obtain care directly, while lower-income families are forced to delay. This creates a two-tiered system where early detection and treatment of dementia—which could otherwise be available to everyone—becomes accessible primarily to those with financial resources.
The Financial Burden on Families Navigating Insurance Barriers
For families already stretched by the costs of neurological care, insurance denials create an impossible choice: appeal the denial, pay out-of-pocket for care, or delay treatment. An appeal process can take 30-60 days, requiring families to gather documentation, obtain letters from their physician, and sometimes hire patient advocates or medical billing specialists. A family paying for all of this—along with the neurological care itself—can face costs exceeding $5,000 to $10,000 or more within a single quarter. Some families hire patient advocates or appeal specialists to fight denials, but this adds another layer of expense. A medical billing consultant might charge $100-300 per hour to review a denial, draft an appeal, and communicate with the insurance company.
Compared to this cost, paying out-of-pocket for an MRI ($800-2,500 uninsured) might seem reasonable—but for a family with limited resources, it’s an unaffordable choice. The trade-off is stark: either spend on appeals and advocacy, spend on care directly, or delay care and hope the condition doesn’t worsen. The long-term cost of delays can far exceed the cost of upfront treatment. Delaying an MRI that could diagnose a treatable form of dementia (like normal-pressure hydrocephalus or a subdural hematoma) might result in missed opportunities for intervention, leading to faster cognitive decline, more behavioral symptoms, earlier need for full-time care, and ultimately higher overall healthcare costs. However, not all families have the luxury of considering these long-term economics when facing an immediate out-of-pocket expense.
Serious Adverse Events: When Delays Cause Harm
The data on adverse outcomes from prior authorization delays is sobering. Nearly 1 in 4 physicians have observed serious patient harm directly attributable to delays in obtaining authorization. For neurological patients, this can mean strokes that could have been prevented with earlier imaging, Parkinson’s symptoms that worsen without timely medication adjustment, or dementia patients who experience falls and injuries while waiting for mobility assessments. One documented case involved a patient with suspected transient ischemic attack (TIA) whose MRI was delayed by prior authorization. The patient suffered a full stroke before the imaging was finally approved, resulting in permanent disability and a significantly worse prognosis.
Another case involved a patient with rapidly progressive cognitive decline whose neurologist recommended advanced PET imaging to confirm Alzheimer’s diagnosis and rule out other causes, but the insurance company denied the request. By the time the denial was overturned after 6 weeks of appeals, the patient had declined significantly, and earlier intervention opportunities had passed. A critical warning: families should not assume that all denials are final or that waiting for an appeal to process is always the safest option. If a neurological symptom is acute—such as sudden weakness, severe headache, vision changes, or acute confusion—seek emergency care immediately and let the hospital billing department handle insurance issues afterward. The prior authorization system is not designed for emergency situations, and delaying emergency evaluation to obtain insurance approval is never appropriate.
Appealing Denials and Fighting Back
When an insurance company denies a neurological care claim, families have the right to appeal. The first step is requesting a written explanation of the denial reason—not all insurers provide clear explanations, but asking specifically for the medical policy justification can reveal whether the denial was based on a valid policy or a routine refusal. Many denials are overturned on appeal, especially when the treating neurologist provides additional clinical documentation. A family appealing an MRI denial, for example, should provide: documentation of cognitive decline (dates of symptom onset, specific changes observed by family or caregivers), the neurologist’s clinical reasoning for why the MRI is necessary, comparison to clinical guidelines (which typically recommend MRI for dementia diagnosis), and any relevant medical history (family history of Alzheimer’s, head trauma, or other neurological risk factors).
Some insurers also respond to letters from the patient’s primary care physician in addition to the neurologist, or requests from family members emphasizing how the delay is affecting quality of life and symptom management. A patient advocate or the neurologist’s office staff can often handle much of this appeals work without additional cost to the family. Many neurological practices have experienced staff who manage insurance issues regularly and know which insurers are most likely to approve certain treatments. The key is asking for help early rather than accepting the initial denial as final.
The Systemic Problem and Future Outlook
The prior authorization crisis in neurological care is not a temporary problem—it reflects fundamental tension between insurance company cost-containment and physician recommendations. Neurological treatments are expensive, and insurance companies use prior authorization as a gate to prevent what they deem unnecessary spending. However, this system relies on non-neurologists making clinical decisions, and it systematically delays care for patients who often cannot afford postponement. Some progress is being made.
State legislatures and the federal government are beginning to regulate prior authorization more strictly, with requirements for faster decision-making timelines and greater clinical transparency. However, comprehensive reform remains incomplete, and families today cannot wait for systemic change. The most effective strategy for neurological patients and their families is to understand the landscape, advocate firmly within the existing system, and seek help from patient advocates, neurologists’ offices, and appeals specialists when necessary. For dementia care in particular—where early detection and intervention can slow disease progression—the stakes of insurance delays could not be higher.
Conclusion
Insurance coverage gaps and prior authorization delays are forcing families to postpone critical neurological care at a time when early diagnosis and treatment matter most. With claim denials rising to 11.8%, advanced imaging approvals being rejected at rates above 24%, and nearly a quarter of physicians reporting serious patient harm from delays, the system is failing neurological patients. The 2026 coverage crisis, as ACA subsidies expire and Medicaid reviews resume, will make these problems worse for millions of older adults who are most vulnerable to neurological disease.
Families facing insurance barriers should not assume denials are final. Request written explanations, gather clinical documentation, appeal systematically, and seek help from patient advocates or your neurologist’s office. For acute neurological symptoms, seek emergency care immediately and address insurance issues afterward. The path forward requires both individual families advocating fiercely within the system and continued pressure on policymakers to reform a system that is currently delaying care for the people who need it most.
You Might Also Like
- Insurance Coverage Gaps Force Families to Delay Critical Neurological Care
- Transportation Infrastructure: The Hidden Key to Better Care Outcomes
- Transportation Infrastructure: The Hidden Key to Better Care Outcomes
For more, see Alzheimer’s Association — caregiving.
